These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7516534)

  • 41. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide.
    Lynn WA; Liu Y; Golenbock DT
    Infect Immun; 1993 Oct; 61(10):4452-61. PubMed ID: 7691750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD14-mediated induction of interleukin-8 and monocyte chemoattractant protein-1 by a heat-resistant constituent of Porphyromonas gingivalis in endothelial cells.
    Mao S; Maeno N; Yoshiie K; Matayoshi S; Fujimura T; Oda H
    Scand J Immunol; 2002 Nov; 56(5):484-91. PubMed ID: 12410798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen.
    Surette ME; Palmantier R; Gosselin J; Borgeat P
    J Exp Med; 1993 Oct; 178(4):1347-55. PubMed ID: 7690833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A region of human CD14 required for lipopolysaccharide binding.
    Viriyakosol S; Kirkland TN
    J Biol Chem; 1995 Jan; 270(1):361-8. PubMed ID: 7529231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of binding and TNF-alpha-inducing ability of chitosans on monocytes: the involvement of CD14.
    Otterlei M; Vårum KM; Ryan L; Espevik T
    Vaccine; 1994 Jul; 12(9):825-32. PubMed ID: 7526573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipopolysaccharides from periodontal pathogens prime neutrophils for enhanced respiratory burst: differential effect of a synthetic lipid a precursor IVA (LA-14-PP).
    Aida Y; Kukita T; Takada H; Maeda K; Pabst MJ
    J Periodontal Res; 1995 Mar; 30(2):116-23. PubMed ID: 7539837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of the endotoxin receptor (CD14) in septic patients.
    Birkenmaier C; Hong YS; Horn JK
    J Trauma; 1992 Apr; 32(4):473-8; discussion 478-9. PubMed ID: 1373777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-4 inhibits the LPS-induced expression of CD14 and monocyte-specific esterase mRNA in MONO-MAC-6 cells.
    Quentmeier H; Kolsdorf K; Zaborski M; Drexler HG
    Leukemia; 1994 Sep; 8(9):1551-6. PubMed ID: 7522293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn.
    Stefanová I; Corcoran ML; Horak EM; Wahl LM; Bolen JB; Horak ID
    J Biol Chem; 1993 Oct; 268(28):20725-8. PubMed ID: 7691802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
    Gallay P; Jongeneel CV; Barras C; Burnier M; Baumgartner JD; Glauser MP; Heumann D
    J Immunol; 1993 Jun; 150(11):5086-93. PubMed ID: 7684419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.
    Pedron T; Girard R; Chaby R
    J Immunol; 1995 Aug; 155(3):1460-71. PubMed ID: 7543522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding sites for endotoxins (lipopolysaccharides) on human monocytes.
    Couturier C; Haeffner-Cavaillon N; Caroff M; Kazatchkine MD
    J Immunol; 1991 Sep; 147(6):1899-904. PubMed ID: 1716284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reducing the bioactivity of Tannerella forsythia lipopolysaccharide by Porphyromonas gingivalis.
    Kim YJ; Lee SH
    J Microbiol; 2014 Aug; 52(8):702-8. PubMed ID: 25098564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.
    Labeta MO; Durieux JJ; Fernandez N; Herrmann R; Ferrara P
    Eur J Immunol; 1993 Sep; 23(9):2144-51. PubMed ID: 7690322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes.
    Gudbrandsdottir S; Hasselbalch HC; Nielsen CH
    J Immunol; 2013 Oct; 191(8):4059-67. PubMed ID: 24048901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Binding of LPS to CD14].
    Grunwald U; Oeser G; Schröder HD; Ritscher D; Schütt C
    Immun Infekt; 1992 Jul; 20(3):86-7. PubMed ID: 1379976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta on calprotectin release in human monocytes.
    Suryono ; Kido J; Hayashi N; Kataoka M; Nagata T
    J Periodontol; 2003 Dec; 74(12):1719-24. PubMed ID: 14974811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases.
    Salvi GE; Collins JG; Yalda B; Arnold RR; Lang NP; Offenbacher S
    J Clin Periodontol; 1997 Jan; 24(1):8-16. PubMed ID: 9049792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.
    Dentener MA; Bazil V; Von Asmuth EJ; Ceska M; Buurman WA
    J Immunol; 1993 Apr; 150(7):2885-91. PubMed ID: 7681082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.
    Hiki N; Berger D; Prigl C; Boelke E; Wiedeck H; Seidelmann M; Staib L; Kaminishi M; Oohara T; Beger HG
    Infect Immun; 1998 Mar; 66(3):1135-41. PubMed ID: 9488406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.